As of January 22, 2025, Arcus Biosciences (RCUS) has a market cap of $1.23 billion USD. According to our data, Arcus Biosciences is ranked No.4904 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.23 B |
-10.01%
|
Dec 31, 2024 | $1.36 B |
-22.04%
|
Dec 29, 2023 | $1.75 B |
-7.64%
|
Dec 30, 2022 | $1.89 B |
-48.90%
|
Dec 31, 2021 | $3.70 B |
55.89%
|
Dec 31, 2020 | $2.38 B |
157.03%
|
Dec 31, 2019 | $0.92 B |
-6.22%
|
Dec 31, 2018 | $0.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Market Cap | = | RCUS Stock Price | * | RCUS Shares Outstanding |
= | $13.40 | * | 91.51 M | |
= | $1.23 B |